Page last updated: 2024-08-24

plerixafor and Cancer of Head

plerixafor has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Folarin, N; Gaken, J; Hersi, HM; Raulf, N; Tavassoli, M	1

Other Studies

1 other study(ies) available for plerixafor and Cancer of Head

Article	Year
MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4. Molecular oncology, 2018, Volume: 12, Issue:12 Topics: Antineoplastic Agents; Benzylamines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclams; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Heterocyclic Compounds; Humans; MicroRNAs; Neoplasm Invasiveness; Prognosis; Receptors, CXCR4; Treatment Outcome	2018

Article

Year

MicroRNA-9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4.

Molecular oncology, 2018, Volume: 12, Issue:12

Topics: Antineoplastic Agents; Benzylamines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclams; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Heterocyclic Compounds; Humans; MicroRNAs; Neoplasm Invasiveness; Prognosis; Receptors, CXCR4; Treatment Outcome

2018